Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10144755 Substituted nucleosides, nucleotides and analogs thereof

Patent 10144755 was granted and assigned to Alios BioPharma, Inc. on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Alios BioPharma, Inc.

0

Current Assignee

Alios BioPharma, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Guangyi Wang0

Leonid Beigelman0

David Bernard Smith0

Date of Patent

December 4, 2018

0

Patent Application Number

152563450

Date Filed

September 2, 2016

0

Patent Citations Received

US Patent 11485753 Substituted nucleosides, nucleotides and analogs thereof

US Patent 10464965 Substituted nucleosides, nucleotides and analogs thereof

US Patent 10485815 Substituted nucleosides, nucleotides and analogs thereof

0

US Patent 10519185 Methods of preparing substituted nucleoside analogs

US Patent 10683320 Substituted nucleosides, nucleotides and analogs thereof

US Patent RE48171 Substituted nucleosides, nucleotides and analogs thereof

US Patent 11021509 Substituted nucleosides, nucleotides and analogs thereof

US Patent 10420788 Substituted nucleosides, nucleotides and analogs thereof

0

...

Patent Primary Examiner

Traviss C Mcintosh, III

0

Patent abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10144755 Substituted nucleosides, nucleotides and analogs thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool